FT Options’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-7,500
Closed -$46K 284
2017
Q2
$46K Buy
+7,500
New +$1.76M 0.08% 114
2016
Q4
Sell
-10,800
Closed -$21K 419
2016
Q3
$21K Buy
10,800
+500
+5% +$122K 0.02% 271
2016
Q2
$102K Sell
10,300
-13,000
-56% -$3M 0.09% 150
2016
Q1
$25K Buy
23,300
+10,800
+86% +$3.09M 0.03% 204
2015
Q4
$57K Buy
+12,500
New +$3.72M 0.04% 148

Other funds holding AGN

FT Options's AGN Position: Q4 2016 in Review

FT Options sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 3,316 shares — an estimated $764K sold.

FT Options first reported a position in AGN in Q4 2015 and held it in 4 quarters. The position peaked at $1.77M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • FT Options reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • FT Options sold 3,316 Allergan plc shares in Q4 2016, an estimated $764K.
  • FT Options first reported a position in Allergan plc in Q4 2015 and held it in 4 quarters.
  • FT Options's Allergan plc position peaked at $1.77M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.